CASP8 and breast carcinoma: Compared with the control group, the levels of cleaved Caspase-3, cleaved Caspase-8 and cleaved PARP were significantly increased in VALD-3-treated breast cancer cells, indicating that VALD-3 could simultaneously activate these proteins (Fig. 5A, C, D).